StockData
Accuray Inc logo

Accuray Inc (ARAY) stock

ARAYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 3/30
$2.80−0.28 (-9.09%)

Close on Nov 13, 2026Market cap $334.43MP/E –Yield –

Accuray r&d expenses

Research and development expenses are spending on new products and technology.

Accuray's R&D Expenses for the twelve months ending Sep 30, 2026 was $34.35M, down 27.0% year over year. For fiscal 2026 it was $37.75M, down 21.3% from the year before. Over ten years it grew -4.0% a year on average. The highest annual figure on record is $81.29M in fiscal 2012.

Annual r&d expenses

PeriodPeriod endValueChange
FY2026Jun 30, 2026$37.75M-21.3%
FY2025Jun 30, 2025$47.94M-3.6%
FY2024Jun 30, 2024$49.73M-12.9%
FY2023Jun 30, 2023$57.13M-1.1%
FY2022Jun 30, 2022$57.75M+9.5%
FY2021Jun 30, 2021$52.73M+5.9%
FY2020Jun 30, 2020$49.78M-11.9%
FY2019Jun 30, 2019$56.49M-1.3%
FY2018Jun 30, 2018$57.25M+14.7%
FY2017Jun 30, 2017$49.92M-11.9%
FY2016Jun 30, 2016$56.65M+1.6%
FY2015Jun 30, 2015$55.75M+3.8%
FY2014Jun 30, 2014$53.72M-18.8%
FY2013Jun 30, 2013$66.20M-18.6%
FY2012Jun 30, 2012$81.29M+96.8%
FY2011Jun 30, 2011$41.30M+31.0%
FY2010Jun 30, 2010$31.52M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Sep 30, 2026$7.81M-30.4%
Q4 FY2026CQ2 2026Jun 30, 2026$7.71M-32.8%
Q3 FY2026CQ1 2026Mar 31, 2026$8.18M-23.7%
Q2 FY2026CQ4 2025Dec 31, 2025$10.65M-21.9%
Q1 FY2026CQ3 2025Sep 30, 2025$11.22M-7.4%
Q4 FY2025CQ2 2025Jun 30, 2025$11.47M+20.4%
Q3 FY2025CQ1 2025Mar 31, 2025$10.71M-1.8%
Q2 FY2025CQ4 2024Dec 31, 2024$13.64M-10.7%
Q1 FY2025CQ3 2024Sep 30, 2024$12.12M-13.5%
Q4 FY2024CQ2 2024Jun 30, 2024$9.53M-32.8%
Q3 FY2024CQ1 2024Mar 31, 2024$10.91M-23.2%
Q2 FY2024CQ4 2023Dec 31, 2023$15.28M+4.4%
Q1 FY2024CQ3 2023Sep 30, 2023$14.01M-0.6%
Q4 FY2023CQ2 2023Jun 30, 2023$14.19M-2.6%
Q3 FY2023CQ1 2023Mar 31, 2023$14.21M+0.7%
Q2 FY2023CQ4 2022Dec 31, 2022$14.64M-0.4%
Q1 FY2023CQ3 2022Sep 30, 2022$14.09M-2.0%
Q4 FY2022CQ2 2022Jun 30, 2022$14.57M-5.1%
Q3 FY2022CQ1 2022Mar 31, 2022$14.10M+6.3%
Q2 FY2022CQ4 2021Dec 31, 2021$14.70M+22.9%
Q1 FY2022CQ3 2021Sep 30, 2021$14.38M+18.4%
Q4 FY2021CQ2 2021Jun 30, 2021$15.36M+25.7%
Q3 FY2021CQ1 2021Mar 31, 2021$13.27M+18.8%
Q2 FY2021CQ4 2020Dec 31, 2020$11.96M-8.5%
Q1 FY2021CQ3 2020Sep 30, 2020$12.15M-8.9%
Q4 FY2020CQ2 2020Jun 30, 2020$12.22M-23.9%
Q3 FY2020CQ1 2020Mar 31, 2020$11.16M-13.5%
Q2 FY2020CQ4 2019Dec 31, 2019$13.06M-4.2%
Q1 FY2020CQ3 2019Sep 30, 2019$13.34M-3.9%
Q4 FY2019CQ2 2019Jun 30, 2019$16.05M+10.0%
Q3 FY2019CQ1 2019Mar 31, 2019$12.91M-8.4%
Q2 FY2019CQ4 2018Dec 31, 2018$13.64M+2.8%
Q1 FY2019CQ3 2018Sep 30, 2018$13.89M+11.3%
Q4 FY2018CQ2 2018Jun 30, 2018$14.59M+22.1%
Q1 FY2018CQ3 2017Sep 30, 2017$14.09M+15.2%
Q4 FY2017CQ2 2017Jun 30, 2017$13.26M–
Q3 FY2017CQ1 2017Mar 31, 2017$12.48M–
Q2 FY2017CQ4 2016Dec 31, 2016$11.94M–
Q1 FY2017CQ3 2016Sep 30, 2016$12.23M–

More Accuray figures

See a number that looks wrong?